Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Congenit Anom (Kyoto) ; 54(3): 150-61, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24666250

RESUMEN

Historical control data on rodent developmental toxicity studies, performed between 1994 and 2010, were obtained from 19 laboratories in Japan, including 10 pharmaceutical and chemical companies and nine contract research organizations. Rats, mice, and hamsters were used for developmental toxicity studies. Data included maternal reproductive findings at terminal cesarean sections and fetal findings including the spontaneous incidences of external, visceral, and skeletal anomalies. No noticeable differences were observed in maternal reproductive data between laboratories. Inter-laboratory variations in the incidences of fetuses with anomalies appeared to be due to differences in the selection of observation parameters, observation criteria, classification of the findings, and terminology of fetal alterations. Historical control data are useful for the appropriate interpretation of experimental results and evaluation of the effects of chemical on reproductive and developmental toxicities.


Asunto(s)
Evaluación Preclínica de Medicamentos/historia , Animales , Grupos Control , Cricetinae , Femenino , Crecimiento y Desarrollo/efectos de los fármacos , Historia del Siglo XX , Historia del Siglo XXI , Masculino , Ratones , Embarazo , Ratas , Reproducibilidad de los Resultados , Proyectos de Investigación
3.
Drug Chem Toxicol ; 30(3): 167-80, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17613004

RESUMEN

A screening study for a vulcanization accelerator N,N-dicyclohexyl-2-benzothiazole-sulfenamide (DCBS) was performed in rats. Rats were given DCBS by gavage daily at 0, 6, 25, 100, or 400 mg/kg. Males were dosed for a total of 44 days beginning 14 days before mating. Females were dosed for a total of 40-51 days beginning 14 days before mating to day 3 of lactation. Toxicologic changes were significantly noted only at 400 mg/kg. Three females died. An increased incidence of females showing decreased locomotor activity, soil of the lower abdominal fur, and reddish tears was observed. A lowered body weight was found in males and females. Increased urinary ketones and serum inorganic phosphorus and decreased serum glutamate pyruvate transaminase in males were found. Increased absolute and relative weights of the kidneys in males and decreased absolute weight of the thymus in both sexes were noted. Significant fatty degeneration of the renal tubular epithelia, vacuolation of the adrenocortical cells, and atrophy of the spleen were observed in females. Significant decreases in the gestation index, numbers of corpura lutea, implantations, pups born and pups born alive, live birth index, and viability index were detected. It is concluded that the No Observed Adverse Effect Levels (NOAELs) for repeat dose and reproductive/developmental toxicity are 100 mg kg-1 day-1 in this screening study.


Asunto(s)
Benzotiazoles/toxicidad , Desarrollo Embrionario/efectos de los fármacos , Reproducción/efectos de los fármacos , Glándulas Suprarrenales/efectos de los fármacos , Glándulas Suprarrenales/patología , Alanina Transaminasa/sangre , Animales , Peso Corporal/efectos de los fármacos , Cuerpo Lúteo/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Implantación del Embrión/efectos de los fármacos , Femenino , Muerte Fetal/inducido químicamente , Viabilidad Fetal/efectos de los fármacos , Edad Gestacional , Cetonas/orina , Riñón/efectos de los fármacos , Riñón/patología , Tamaño de la Camada/efectos de los fármacos , Masculino , Actividad Motora/efectos de los fármacos , Nivel sin Efectos Adversos Observados , Tamaño de los Órganos/efectos de los fármacos , Fósforo/sangre , Embarazo , Ratas , Ratas Sprague-Dawley , Bazo/efectos de los fármacos , Bazo/patología , Lágrimas/efectos de los fármacos , Timo/efectos de los fármacos , Timo/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA